Data / Form D filings / InVasc Therapeutics, Inc.
InVasc Therapeutics, Inc.: Form D filing
InVasc Therapeutics, Inc., a biotechnology company in Tucker, GA, filed a Form D with the SEC in 2010. The latest, on July 13, 2010, reports $3.2 million sold of a $12 million offering to 3 investors.
Find out what InVasc Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3562 HABERSHAM AT NORTHLAKE, BUILDING J, SUITE A, Tucker, GA, 30084
- Phone
- (678) 736-5903
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2010
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1496449
The full lists. Form D filings in Georgia: 1,337 rows, $66.85, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 13, 2010 | New notice | $12,000,000 | $3,150,001 | $8,849,999 | 3 | Jun 28, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| William D. Schaeffer | Executive Officer, Director | |
| William D. Johnston | Executive Officer, Director | |
| Daniele D. Cardoso | Director | |
| Larry D. Dillaha | Director |
Other biotechnology companies in Georgia that filed recently
- Opus Medical Therapies, LLC $485,089 · Sep 22, 2026
- Airway Therapeutics, Inc. $43.5 million · Sep 9, 2026
- FEMASYS INC $30 million · Aug 20, 2026
Every Form D from the week of Jul 12, 2010 · All recent filings in Georgia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what InVasc Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.